![Atmosphere | Free Full-Text | Long-Term Trends in PAH Concentrations and Sources at Rural Background Site in Central Europe | HTML Atmosphere | Free Full-Text | Long-Term Trends in PAH Concentrations and Sources at Rural Background Site in Central Europe | HTML](https://www.mdpi.com/atmosphere/atmosphere-10-00687/article_deploy/html/images/atmosphere-10-00687-g006.png)
Atmosphere | Free Full-Text | Long-Term Trends in PAH Concentrations and Sources at Rural Background Site in Central Europe | HTML
Characterizing Spatial Diversity of Passive Sampling Sites for Measuring Levels and Trends of Semivolatile Organic Chemicals | Environmental Science & Technology
The acceleration of cardiomyogenesis in embryonic stem cells in vitro by serum depletion does not increase the number of developed cardiomyocytes | PLOS ONE
![🔴Live: Welcome to ICOM Prague 2022! - International Council of Museums -International Council of Museums 🔴Live: Welcome to ICOM Prague 2022! - International Council of Museums -International Council of Museums](https://icom.museum/wp-content/uploads/2022/08/277804619_2652019888275289_6051268943082176552_n-1024x536.jpeg)
🔴Live: Welcome to ICOM Prague 2022! - International Council of Museums -International Council of Museums
![IJMS | Free Full-Text | Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients | HTML IJMS | Free Full-Text | Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients | HTML](https://www.mdpi.com/ijms/ijms-21-07295/article_deploy/html/images/ijms-21-07295-g001.png)
IJMS | Free Full-Text | Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients | HTML
![PDF) A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida) PDF) A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)](https://i1.rgstatic.net/publication/354345538_A_randomized_placebo-controlled_phase_2_study_of_paclitaxel_in_combination_with_reparixin_compared_to_paclitaxel_alone_as_front-line_therapy_for_metastatic_triple-negative_breast_cancer_fRida/links/6132cdc20360302a007a734f/largepreview.png)